Journal Article

Distinguishing Separable Domains of Cognition in Human and Animal Studies: What Separations Are Optimal for Targeting Interventions? A Summary of Recommendations From Breakout Group 2 at the Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference

Keith H Nuechterlein, Trevor W Robbins and Haim Einat

in Schizophrenia Bulletin

Published on behalf of Maryland Psychiatric Research Center

Volume 31, issue 4, pages 870-874
Published in print January 2005 | ISSN: 0586-7614
Published online January 2005 | e-ISSN: 1745-1701 | DOI: http://dx.doi.org/10.1093/schbul/sbi047
Distinguishing Separable Domains of Cognition in Human and Animal Studies: What Separations Are Optimal for Targeting Interventions? A Summary of Recommendations From Breakout Group 2 at the Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference

More Like This

Show all results sharing this subject:

  • Child and Adolescent Psychiatry

GO

Show Summary Details

Preview

At the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) New Approaches Conference, a discussion group focused on directions for future research that are critical to enhancing our understanding of the distinctions among key cognitive domains that have relevance for the development of cognition-enhancing interventions. One set of recommendations emphasizes the need for examining and optimizing the psychometric properties of relevant measurement paradigms from cognitive psychology and cognitive neuroscience. This step is critical to translating many notable advances in these basic fields into measures that would be appropriate for clinical trials. A second set of recommendations focuses on key directions for the development and application of animal models of cognitive processes that would greatly aid the discovery and preclinical testing of potential cognition-enhancing agents. As part of this process, the group noted several existing animal paradigms that have particular promise as measures in the key cognitive domains in schizophrenia identified by the MATRICS Neurocognition Committee.

Keywords: neurocognition; clinical trials; behavioral neuroscience

Journal Article.  3019 words. 

Subjects: Child and Adolescent Psychiatry

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.